Figure 3.Independent prognostic evaluation of ICDRLs prognostic features. (A, B) Univariate and multivariate COX analysis calculating HR and p-values for different clinical-pathological variables and ICDRLs prognostic features. (C) Development of a nomogram based on different clinical-pathological variables and ICDRLs prognostic features. (D–K) Clinical survival outcome evaluation of risk subgroups based on ICDRLs prognostic features in different clinical-pathological features.
